(Q35014566)

English

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review (English)

1 reference

Europe PubMed Central

5 August 2017

Patricia R Houck

5

object named as

Patricia Houck

1 reference

Europe PubMed Central

5 August 2017

author name string

K N Roy Chengappa

1

1 reference

Europe PubMed Central

5 August 2017

L Chalasani

2

1 reference

Europe PubMed Central

5 August 2017

Jaspreet S Brar

3

1 reference

Europe PubMed Central

5 August 2017

H Parepally

4

1 reference

Europe PubMed Central

5 August 2017

Joseph Levine

6

1 reference

Europe PubMed Central

5 August 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

5 August 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

5 August 2017

24

1 reference

Europe PubMed Central

5 August 2017

10

1 reference

Europe PubMed Central

5 August 2017

1576-1584

1 reference

Europe PubMed Central

5 August 2017

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium and weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and endocrine disorders in women taking valproate for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Topiramate as add-on treatment for patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label adjunctive topiramate in the treatment of bipolar disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of overweight and obesity in patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychotropic drug prescription patterns among patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonadherence with mood stabilizers: prevalence and predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980061-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80061-3

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35014566&oldid=2050696942"